Consistent with the insulin resistance function, TAK1 specific inhibitor 5Z-7-OX almost completely offset the positive regulation of TRIM8 on liver weight gain, lipid accumulation and abnormal liver function. Here, MAP3K7 is linked to Insulin resistance.